Reverse lookup

Mutual funds holding Glenmark Pharmaceuticals

57 active mutual fund schemes hold Glenmark Pharmaceuticals as of 30 Aug 2026, sorted by weight.

#FundCategoryWeightFund AUM

Between disclosures

What funds did with Glenmark Pharmaceuticals

28 Apr 2026 → 30 Aug 2026each fund against its own two filings

6added26trimmed1exited

Weight is the stock's share of each scheme's portfolio, compared between that scheme's own last two full disclosures — funds disclose on their own timetable, so the two dates are not identical for every fund. Schemes whose latest filing was incomplete are left out rather than differenced against a partial portfolio.

How this page is produced

Every figure above is computed from the monthly portfolio disclosures each AMC files with the exchanges, as last disclosed 30 Aug 2026. The full method is published, including its limitations.

Holdings are disclosed monthly, so this list reflects the most recent disclosure — not live positions. A fund may have bought or sold since. The comparison above differences each scheme against its own previous full disclosure, so it shows what changed between filings, not what changed today.

Written and maintained by Azad Mohammed, who built the pipeline these numbers come out of. Found an error? Tell us — corrections are made and the page rebuilds within the hour.

This page describes what has already happened. It is not investment advice and not a recommendation to buy or sell any security. Arthkar is not a SEBI-registered investment adviser or research analyst, and does not provide or arrange investment advice. Investments in securities are subject to market risk.